Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Retinal Neoplasms × Melphalan × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 249 Lymphoma 128 Leukemia, Myeloid, Acute 101 Lymphoma, Non-Hodgkin 98 Precursor Cell Lymphoblastic Leukemia-Lymphoma 93 Neoplasms, Plasma Cell 91 Myelodysplastic Syndromes 89 Leukemia 79 Hodgkin Disease 78 Lymphoma, Large B-Cell, Diffuse 66 Leukemia, Lymphocytic, Chronic, B-Cell 65 Lymphoma, Mantle-Cell 59 Lymphoma, Follicular 57 Neuroblastoma 44 Burkitt Lymphoma 44 Lymphoma, Large-Cell, Immunoblastic 40 Lymphoma, B-Cell, Marginal Zone 37 Recurrence 34 Myeloproliferative Disorders 32 Hematologic Neoplasms 32 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30 Immunoglobulin Light-chain Amyloidosis 29 Leukemia, Myeloid, Accelerated Phase 25 Leukemia, Myeloid, Chronic-Phase 24 Congenital Abnormalities 24 Leukemia, Myelomonocytic, Chronic 23 Graft vs Host Disease 23 Dendritic Cell Sarcoma, Interdigitating 21 Waldenstrom Macroglobulinemia 20 Melanoma 20

Interventions

Etoposide 3 Carboplatin 3 Vincristine 2 Topotecan 1 Platinum Compounds 1 Melphalan 1 Lasers, Semiconductor 1 Lasers 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Eye Enucleation 1 Drug Therapy 1 Doxorubicin 1 Cyclophosphamide 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡